IRHIS Project

Interoperable Remote Health Innovation brought to Scale

IRHIS aims to establish the first EU-wide Advanced Remote Care Demonstration Chain. It is meant to collaboratively scale Advanced Remote Care Tech Champions across Europe’s Less Developed Regions. For that purpose, IRHIS partners will build 3 Interregional DemoScale Labs, accelerating the upscale of advanced AI-powered MedTech solutions. The Labs will deal with 3 of the most critical EU remote care areas: musculoskeletal rehabilitation, neurological disorder treatment and critical patient conditions (ICU).

In practice, the IRHIS consortium will work with 8 key technologies developed by innovative scale-up SMEs from Lithuania, Greece, Bulgaria, Belgium, Spain and Portugal. To ensure a user-centric approach of the development, more than 1.000 patients will be involved in testing and evaluation activities, collecting millions of big data entries. Processing this data will enable robust AI and Machine Learning model developments to ensure market fit and adoption of the IRHIS technologies. Further, clinical relevance will be created throughout 2 years of continuous, parallel and iterative testing across the 3 DemoScale Labs backed by our 20 partners from 13 EU Regions. Our interregional leverage will thus lie in data, tech (integration) and patients.

Ergobyte actively participates at DemoScale Lab 2, focussing on neurological disorders. Along with our unique partners, our researchers will combine rehab and sensor technology with business process optimization tools to enhance prevention and improve rehabilitation outcomes.

Beyond technology deployment, IRHIS also seeks to consolidate the fragmented EU remote care innovation landscape, mobilizing crucial investments, fostering interoperability and harnessing the potential of a rapidly evolving field that promises improved patient journeys, predictive rehabilitation and transformative care solutions. The consortium envisions the establishment of a dynamic EU-wide ecosystem, with a focus on empowering innovators from Less Developed Regions.